Please enable JS

DISCOVER

our Quality & credentials

Quality Management
at the very centre
of the Telemedicine Technologies corporate
strategy

ISO 9001:2015 certification
ISO 27001 HDS



Regulatory compliance:
21 CRF part 11 FDA





CDISC-ODM Certification




Information System Validation:
GAMP-5 methodology


National Qualiopi certification,
a new quality guarantee for
training providers in France

BSMA Europe (Bio Supply Management Alliance) Award received in October 2024 for the CleanWeb™-RTSM module, which streamlines supply management for randomised trials

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Click and xShare: transforming health data access for patients in Europe

May 27, 2025

28 May 2025 – 04:00 PM to 05:00 PM CET (Webinar) Yoanni Th. Matsakis, President of Telemedicine Technologies, attends the first xShare webinar on the EHDS Adoption Kit for citizens. The event introduces the European Health Data Space (EHDS) and the European Electronic Health Record Exchange Format (EEHRxF). It explores data-driven healthcare through “The Health […]

READ MORE
telemedecine technologies news

AI is finding broader use in healthcare, and it’s not just for speedy drug R&D anymore

May 27, 2025

Med City News Artificial intelligence is being incorporated into more places in healthcare, for uses such as guiding clinical trial enrollment as well as helping physicians get up to speed on a patient’s history. A panel discussed these applications and more during MedCity News’s INVEST conference in Chicago. In the life sciences community, there’s a […]

READ MORE
telemedecine technologies news

Harnessing Technology and Adopting Unified Approaches to Optimize Pharmacovigilance Activities

May 27, 2025

Applied Clinical Trials Online The need for unified, digital-first pharmacovigilance Diverse data sources and a global pharmacovigilance (PV) market mean we need to urgently adopt new, unified approaches to PV. At the same time, patient centricity, an increase in support programs, complex medicines, combination products, as well as the rise of personalized medicine are all […]

READ MORE